We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Speculating in Takeover Targets
CTG 10.49+0.1%Dec 8 4:30 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
From: E_K_S10/3/2019 8:28:43 AM
1 Recommendation  Read Replies (1) of 6850
DuPont to buy membrane biofiltration business from Evoqua Water
Oct. 3, 2019 7:25 AM ET|About: DuPont de Nemours, Inc. (DD)|By: Carl Surran, SA News Editor

DuPont (NYSE: DD) agrees to acquire the Memcor product line of ultrafiltration and membrane biofiltration technologies from Evoqua Water Technologies (NYSE: AQUA) for an undisclosed sum.

Combined with the planned acquisition of BASF's ultrafiltration business, DuPont says the deal will position it to provide the products, technology and geographic diversification needed to meet current and future customer demand.

Evoqua says the Memcor sale allows it to focus on core products and solutions in line with its strategy toward digitally enabled, recurring revenue-based businesses.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext